Showing results (271-280 of 354) with videos related to
Sort By:
Pageof 36
BMC Medicine|April 11, 2015
Multi-omic signature of body weight change: results from a population-based cohort studySimone Wahl, Susanne Vogt, Ferdinand Stückler, et al.European Heart Journal|April 6, 2017
Symmetric dimethylarginine, high-density lipoproteins and cardiovascular diseaseStephen Zewinger, Marcus E Kleber, Lucia Rohrer, et al.BMJ (Clinical Research Ed.)|June 19, 2014
Vitamin D and mortality: meta-analysis of individual participant data from a large consortium of cohort studies from Europe and the United StatesBen Schöttker, Rolf Jorde, Anne Peasey, et al.European Heart Journal|April 28, 2017
Lipoprotein(a) and the risk of cardiovascular disease in the European population: results from the BiomarCaRE consortiumChristoph Waldeyer, Nataliya Makarova, Tanja Zeller, et al.Plos One|December 14, 2011
RANTES/CCL5 and risk for coronary events: results from the MONICA/KORA Augsburg case-cohort, Athero-Express and CARDIoGRAM studiesChristian Herder, Wouter Peeters, Thomas Illig, et al.Addiction (Abingdon, England)|June 9, 2021
Alcohol intake and total mortality in 142 960 individuals from the MORGAM Project: a population-based studyAugusto Di Castelnuovo, Simona Costanzo, Marialaura Bonaccio, et al.JAMA Cardiology|November 4, 2020
Association of Circulating Monocyte Chemoattractant Protein-1 Levels With Cardiovascular Mortality: A Meta-analysis of Population-Based StudiesMarios K Georgakis, James A de Lemos, Colby Ayers, et al.Age and Ageing|January 26, 2023
Grip strength values and cut-off points based on over 200,000 adults of the German National Cohort - a comparison to the EWGSOP2 cut-off pointsMarie-Theres Huemer, Alexander Kluttig, Beate Fischer, et al.Plos Genetics|December 3, 2010
Genome-wide association study identifies two novel regions at 11p15.5-p13 and 1p31 with major impact on acute-phase serum amyloid ACarola Marzi, Eva Albrecht, Pirro G Hysi, et al.Journal of the American College of Cardiology|July 3, 2024
Impact of Lipoprotein(a) Level on Low-Density Lipoprotein Cholesterol- or Apolipoprotein B-Related Risk of Coronary Heart DiseaseNatalie Arnold, Christopher Blaum, Alina Goßling, et al.Pageof 36